A Novel, Selective c-Abl Inhibitor, Compound 5, Prevents Neurodegeneration in Parkinson's Disease (vol 64, pg 15091, 2021)

被引：0
|
作者：
Kwon, Seung-Hwan
Kim, Sangjune
Park, A. Yeong
Lee, Saebom
Gadhe, Changdev Gorakshnath
Seo, Bo Am
Park, Jong-Sung
Jo, Suyeon
Oh, Yumin
Kweon, Sin Ho
Ma, Shi-Xun
Kim, Wonjoong R.
Kim, Misoon
Kim, Hyeongjun
Kim, Jae Eun
Lee, Seulki
Lee, Jinhwa
Ko, Han Seok
机构：
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2021年 / 64卷 / 24期
关键词：
D O I：
10.1021/acs.jmedchem.1c01988
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：18237 / 18237
页数：1
相关论文
共 20 条
  • [1] A Novel, Selective c-Abl Inhibitor, Compound 5, Prevents Neurodegeneration in Parkinson's Disease
    Kwon, Seung-Hwan
    Kim, Sangjune
    Park, A. Yeong
    Lee, Saebom
    Gadhe, Changdev Gorakshnath
    Seo, Bo Am
    Park, Jong-Sung
    Jo, Suyeon
    Oh, Yumin
    Kweon, Sin Ho
    Ma, Shi-Xun
    Kim, Wonjoong R.
    Kim, Misoon
    Kim, Hyeongjun
    Kim, Jae Eun
    Lee, Seulki
    Lee, Jinhwa
    Ko, Han Seok
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (20) : 15091 - 15110
  • [2] C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease
    Abushouk, Abdelrahman Ibrahim
    Negida, Ahmed
    Elshenawy, Rasha Abdelsalam
    Zein, Hossam
    Hammad, Ali M.
    Menshawy, Ahmed
    Mohamed, Wael M. Y.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2018, 17 (01) : 14 - 21
  • [3] The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson's disease
    Karuppagounder, Senthilkumar S.
    Wang, Hu
    Kelly, Terence
    Rush, Roger
    Nguyen, Richard
    Bisen, Shivani
    Yamashita, Yoko
    Sloan, Nicholas
    Dang, Brianna
    Sigmon, Alexander
    Lee, Hyeun Woo
    Lee, Shirley Marino
    Watkins, Leslie
    Kim, Erica
    Brahmachari, Saurav
    Kumar, Manoj
    Werner, Milton H.
    Dawson, Ted M.
    Dawson, Valina L.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (679)
  • [4] The c-Abl/p73 pathway induces neurodegeneration in a Parkinson?s disease model
    Marin, Tamara
    Valls, Cristian
    Jerez, Carolina
    Huerta, Tomas
    Elgueta, Daniela
    Vidal, Rene L.
    Alvarez, Alejandra R.
    Cancino, Gonzalo I.
    IBRO NEUROSCIENCE REPORTS, 2022, 13 : 378 - 387
  • [5] The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson's disease mouse model
    Lee, Saebom
    Kim, Sangjune
    Park, Yong Joo
    Yun, Seung Pil
    Kwon, Seung-Hwan
    Kim, Donghoon
    Kim, Dong Yeon
    Shin, Jae Soo
    Cho, Dae Jin
    Lee, Gong Yeal
    Ju, Hyun Soo
    Yun, Hyo Jung
    Park, Jae Hong
    Kim, Wonjoong Richard
    Jung, Eun Ah
    Lee, Seulki
    Ko, Han Seok
    HUMAN MOLECULAR GENETICS, 2018, 27 (13) : 2344 - 2356
  • [6] A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's disease
    Simuni, Tanya
    Merchant, Kalpana
    PARKINSONISM & RELATED DISORDERS, 2023, 108
  • [7] The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
    Karuppagounder, Senthilkumar S.
    Brahmachari, Saurav
    Lee, Yunjong
    Dawson, Valina L.
    Dawson, Ted M.
    Ko, Han Seok
    SCIENTIFIC REPORTS, 2014, 4
  • [8] The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
    Senthilkumar S. Karuppagounder
    Saurav Brahmachari
    Yunjong Lee
    Valina L. Dawson
    Ted M. Dawson
    Han Seok Ko
    Scientific Reports, 4
  • [9] Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson's Disease Model
    Imam, Syed Z.
    Trickler, William
    Kimura, Shinya
    Binienda, Zbigniew K.
    Paule, Merle G.
    Slikker, William, Jr.
    Li, Senlin
    Clark, Robert A.
    Ali, Syed F.
    PLOS ONE, 2013, 8 (05):
  • [10] Plasma and cerebrospinal fluid pharmacokinetics of vodobatinib, a neuroprotective c-Abl tyrosine kinase inhibitor for the treatment of Parkinson?s disease
    Walsh, Ryan R.
    Damle, Nitin K.
    Mandhane, Sanjay
    Piccoli, Steven P.
    Talluri, Ravi S.
    Love, Damon
    Yao, Siu-Long
    Ramanathan, Vikram
    Hurko, Orest
    PARKINSONISM & RELATED DISORDERS, 2023, 108
12